Logotype for CellaVision

CellaVision (CEVI) investor relations material

CellaVision Q3 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for CellaVision
Q3 2025 earnings summary6 Nov, 2025

Executive summary

  • Net sales declined by 1.7%–2% to SEK 176 million, with organic sales up 2.6% year-over-year despite a -4.3% FX headwind and mixed regional performance.

  • EBITDA rose to SEK 50 million, margin improved to 28%, and gross margin increased to 69%, reflecting operational efficiency.

  • Strategic progress included completion of a clinical trial and CE mark submission for the bone marrow application, with approval expected in early 2026.

  • Major software upgrade completed and validated, with rollout planned for the current quarter.

  • Cash flow from operating activities was SEK 29.6–30 million, impacted by working capital changes.

Financial highlights

  • Gross margin increased to 69%, up 1 percentage point year-over-year, aided by price increases and favorable product mix.

  • EBITDA for Q3: SEK 50 million (up from SEK 49 million); EBITDA margin: 28%.

  • Operating expenses totaled SEK 82 million, with reductions in sales/admin and increased R&D investment.

  • R&D investment was 24% of sales, with SEK 14 million capitalized, lower than usual due to vacation and software completion.

  • Cash and cash equivalents at quarter-end: SEK 159 million.

Outlook and guidance

  • CE mark for bone marrow application expected early 2026, with commercial launch activities planned for Q1 2026.

  • Software upgrade is expected to drive growth by enhancing product differentiation, with no additional fee for customers.

  • Continued R&D investment is planned, with possible changes in capitalization as projects mature or complete.

  • Management remains confident in long-term growth and value creation across all regions despite quarterly fluctuations.

  • U.S. reagent market entry expected mid-2026, with methanol-free stain as a key enabler.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next CellaVision earnings date

Logotype for CellaVision
Q4 20255 Feb, 2026
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next CellaVision earnings date

Logotype for CellaVision
Q4 20255 Feb, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

CellaVision AB offers systems for automated and digital analysis of body fluids in health care services sector. It provides digital solutions for blood and body fluids analysis; image-based systems for microscopic analysis and clinical review of body fluids, such as peripheral blood film, and urine analysis; lab automation solutions; and software solutions, including Cellavision DM96, a complete solution that consists of an analyzer, instrument camera, computer, software environment with proprietary algorithms, ready-to-use reagents, and quality control material. The company also has integration solutions to hospital information systems and other laboratory systems. CellaVision AB was incorporated in 1994 and is headquartered in Lund, Sweden.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage